collaboration with Takeda Pharmaceuticals for its commercialization upon expected approval. The competitors of the company include Roche Holding AG ( OTCQX:RHHBY ), GlaxoSmithKline plc. ( GSK ), Arena Pharmaceuticals ( ARNA ), and Vivus Inc. ( VVUS ). Except GSK
Nov 18 (Reuters) - Roche Holding AG : * Vontobel raises target price to Sfr 270 from Sfr 263; rating buy For a summary of rating actions and price target changes
Nov 1 (Reuters) - U.S. regulators on Friday approved Roche Holding AG 's new drug for patients with chronic lymphocytic leukemia (CLL) who have not previously been treated for one of the most common forms of blood cancer.
Nov 1 (Reuters) - U.S. regulators said on Friday they approved a new treatment from Roche Holding AG for patients with chronic lymphocytic leukemia who have not previously been treated for the blood...
Two thirds of Roche's pharmaceutical sales stem from Genentech. Roche needs to expand prescribing labels and develop next-generation versions to support growth from novel drugs.Roche relies on three cancer drugs--Rituxan, Avastin, and Herceptin--to provide 40% of revenue. If tighter budgets lead to
(Reuters) - Shares of Alexion Pharmaceuticals Inc rose more than 7 percent on Tuesday following a report that Swiss drugmaker Roche Holding AG made an informal approach to the biotech company last...
for Health Care and Technology. Five of the fund's top 10 holdings-- Biogen Idec BIIB, Amgen AMGN, Eli Lilly LLY, Roche Holding AG , and Novartis AG NVS--are Health Care names, which accounted for 33% of Vanguard PRIMECAP's stock holdings at the
for example, the fund has shed stocks that have done well since purchase and looked fairly valued, such as drugmaker Roche Holding AG RHHBY and document-storage company Iron Mountain IRM. As a result, the fund is more concentrated in its top 10 than
considerations are described more fully in the Franklin Income Fund and Franklin Balanced Fund prospectuses. 1. As of 9/30/12, Roche Holding AG represented 1.09% of Franklin Income Fund total net assets. Holdings subject to change. 2. As of 9/30/12, Vodafone